TransMolecular News
Most Popular TransMolecular Story
Emerging Drug Developer: TransMolecular
TransMolecular stays focused on a unique cancer program There's one key point that the CEO of Cambridge, MA-based TransMolecular wants everyone to know up front. "We are not using scorpion venom," Read more...
Latest Headlines
- October 6, 2008
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
